Prime Medicine (PRME) Retained Earnings (2021 - 2026)
Prime Medicine (PRME) posted Retained Earnings of $1.0 billion for Q1 2026, up 214.16% on a QoQ basis from -$888.4 million in Q4 2025, and up 6761266.67% year-over-year from N/an in Q1 2025.
Prime Medicine (PRME) Retained Earnings (2021 - 2026) Analysis & Trends
Prime Medicine's Retained Earnings history runs 6 years deep, the most recent figure standing at $1.0 billion for Q1 2026.
- Quarterly Retained Earnings rose 6761266.67% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 6761266.67% YoY) and the FY2025 annual result came in at -$888.4 million, down 88835500.0% from the prior year.
- Retained Earnings was $1.0 billion for Q1 2026 at Prime Medicine, up from -$888.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $1.0 billion in Q1 2026 and bottomed at -$888.4 million in Q4 2025.
- A 5-year average of $953466.7 and a median of -$15000.0 in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2025 — Retained Earnings slumped 88835500.0% — and 2026, when it jumped 6761266.67%.
- Prime Medicine's Retained Earnings stood at $609.8 million in 2022, then sank by 100.0% to -$15000.0 in 2023, then soared by 106.67% to $1000.0 in 2024, then slumped by 88835500.0% to -$888.4 million in 2025, then jumped by 214.16% to $1.0 billion in 2026.
- Business Quant data shows PRME's Retained Earnings at $1.0 billion in Q1 2026, -$888.4 million in Q4 2025, and $33000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Prime Medicine | 525.98 Mn | 525.98 Mn | - | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.01 Bn |
| Dec 31, 2025 | -888.35 Mn |
| Sep 30, 2025 | 33,000.00 |
| Jun 30, 2025 | -791.69 Mn |
| Mar 31, 2025 | -15,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 834.42 Mn |
| Jun 30, 2024 | -592.40 Mn |
| Mar 31, 2024 | -537.10 Mn |
| Dec 31, 2023 | -15,000.00 |
| Sep 30, 2023 | 619.79 Mn |
| Jun 30, 2023 | -268,000.00 |
| Mar 31, 2023 | -205,000.00 |
| Dec 31, 2022 | 609.85 Mn |
| Sep 30, 2022 | -253.91 Mn |
| Dec 31, 2021 | 15.16 Mn |